Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
Urologic Oncology: Seminars and Original Investigations.
Times cited: 5
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Times cited: 92
Treatment of patients with metastatic urothelial cancer "Unfit" for cisplatin-based chemotherapy.
Journal of Clinical Oncology.
Times cited: 114
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
Seminars in Oncology.
Times cited: 75